rs1800629
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The variant allele was found at a frequency of 0.131 in 474,386 control chromosomes in the GnomAD database, including 4,807 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).
Frequency
Genomes: 𝑓 0.14 ( 1582 hom., cov: 31)
Exomes 𝑓: 0.13 ( 3225 hom. )
Consequence
Unknown
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0180
Publications
3734 publications found
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.
Variant Effect in Transcripts
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Frequencies
GnomAD3 genomes AF: 0.138 AC: 20989AN: 152008Hom.: 1578 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
20989
AN:
152008
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.116 AC: 17554AN: 150892 AF XY: 0.118 show subpopulations
GnomAD2 exomes
AF:
AC:
17554
AN:
150892
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.128 AC: 41363AN: 322260Hom.: 3225 Cov.: 0 AF XY: 0.125 AC XY: 22845AN XY: 183234 show subpopulations
GnomAD4 exome
AF:
AC:
41363
AN:
322260
Hom.:
Cov.:
0
AF XY:
AC XY:
22845
AN XY:
183234
show subpopulations
African (AFR)
AF:
AC:
1151
AN:
9350
American (AMR)
AF:
AC:
1749
AN:
28742
Ashkenazi Jewish (ASJ)
AF:
AC:
903
AN:
11246
East Asian (EAS)
AF:
AC:
806
AN:
10602
South Asian (SAS)
AF:
AC:
4580
AN:
60236
European-Finnish (FIN)
AF:
AC:
1878
AN:
14012
Middle Eastern (MID)
AF:
AC:
481
AN:
2824
European-Non Finnish (NFE)
AF:
AC:
27754
AN:
169932
Other (OTH)
AF:
AC:
2061
AN:
15316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1608
3216
4824
6432
8040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.138 AC: 20992AN: 152126Hom.: 1582 Cov.: 31 AF XY: 0.132 AC XY: 9824AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
20992
AN:
152126
Hom.:
Cov.:
31
AF XY:
AC XY:
9824
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
5287
AN:
41508
American (AMR)
AF:
AC:
1330
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
291
AN:
3470
East Asian (EAS)
AF:
AC:
353
AN:
5168
South Asian (SAS)
AF:
AC:
332
AN:
4814
European-Finnish (FIN)
AF:
AC:
1299
AN:
10604
Middle Eastern (MID)
AF:
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11606
AN:
67968
Other (OTH)
AF:
AC:
262
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
921
1841
2762
3682
4603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
243
AN:
3478
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:drug response
Revision:reviewed by expert panel
Pathogenic
VUS
Benign
Condition
-
1
-
Susceptibility to severe coronavirus disease (COVID-19) (1)
-
1
-
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR4 (1)
-
-
-
Endometriosis (1)
-
-
-
etanercept response - Efficacy (1)
-
-
-
HUMAN IMMUNODEFICIENCY VIRUS DEMENTIA, SUSCEPTIBILITY TO (1)
-
-
-
Inherited susceptibility to asthma (1)
-
-
-
Malaria, cerebral, susceptibility to (1)
-
-
-
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO (1)
-
-
-
Psoriatic arthritis, susceptibility to (1)
-
-
-
SEPTIC SHOCK, SUSCEPTIBILITY TO (1)
-
-
-
Systemic lupus erythematosus, susceptibility to (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.